{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=62", "query": { "intervention": "standard of care treatment", "page": 62 }, "page_size": 10 }, "pagination": { "page": 62, "page_size": 10, "total_count": 9593, "total_pages": 960, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=63&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=standard+of+care+treatment&page=61&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T05:20:10.840Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05446870", "title": "Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "High-grade Serous Ovarian Carcinoma", "Ovarian Carcinoma" ], "interventions": [ { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Avastin", "type": "BIOLOGICAL" }, { "name": "MK-4830", "type": "BIOLOGICAL" }, { "name": "Docetaxel", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 160, "start_date": "2022-07-25", "completion_date": "2024-10-16", "has_results": true, "last_update_posted_date": "2025-10-01", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 12, "location_summary": "Aurora, Colorado • Jacksonville, Florida • Miami, Florida + 8 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT05446870" }, { "nct_id": "NCT05766670", "title": "Intramedullary Calcium Sulfate Antibiotic Depot", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Open tíbia Fracture", "Osteomyelitis Tibia", "Tibial Fractures" ], "interventions": [ { "name": "Vancomycin Hydrochloride", "type": "DRUG" }, { "name": "Gentamicin", "type": "DRUG" }, { "name": "Standard Intramedullary Nail", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 242, "start_date": "2024-04-08", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 12, "location_summary": "Los Angeles, California • Macon, Georgia • Chicago, Illinois + 9 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Macon", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05766670" }, { "nct_id": "NCT03125070", "title": "Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hematopoietic and Lymphoid Cell Neoplasm" ], "interventions": [ { "name": "Best Practice and Internet site with links to existing resources", "type": "OTHER" }, { "name": "Internet, Mobile app and Telehealth Intervention", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 546, "start_date": "2020-10-29", "completion_date": "2023-12-31", "has_results": true, "last_update_posted_date": "2025-01-29", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 15, "location_summary": "Tampa, Florida • Maywood, Illinois • Kansas City, Kansas + 10 more", "locations": [ { "city": "Tampa", "state": "Florida" }, { "city": "Maywood", "state": "Illinois" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03125070" }, { "nct_id": "NCT04759183", "title": "Virtual Reality Experiences for Anxiety and Pain Control", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hematopoietic and Lymphoid Cell Neoplasm", "Malignant Solid Neoplasm" ], "interventions": [ { "name": "Survey Administration", "type": "OTHER" }, { "name": "Virtual Reality Game", "type": "PROCEDURE" }, { "name": "Virtual Reality Meditation", "type": "PROCEDURE" } ], "intervention_types": [ "OTHER", "PROCEDURE" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 32, "start_date": "2021-03-05", "completion_date": "2022-08-25", "has_results": false, "last_update_posted_date": "2022-09-07", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04759183" }, { "nct_id": "NCT03636256", "title": "Evaluation of NanoDoce® in Participants With Urothelial Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bladder Cancer", "Urothelial Carcinoma", "Urinary Bladder Neoplasm", "Urinary Bladder Cancer", "Urogenital Neoplasms", "Urologic Neoplasms", "Urologic Cancer", "Malignant Tumor of the Urinary Bladder", "Cancer of the Bladder" ], "interventions": [ { "name": "NanoDoce (direct injection)", "type": "DRUG" }, { "name": "NanoDoce (intravesical instillation) - Visit 2 Instillation", "type": "DRUG" }, { "name": "Institutional Standard of Care", "type": "OTHER" }, { "name": "NanoDoce (intravesical instillation) - Induction and Maintenance Instillations", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NanOlogy, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2019-04-02", "completion_date": "2021-11-02", "has_results": true, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Baltimore, Maryland • New York, New York + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "New York", "state": "New York" }, { "city": "Myrtle Beach", "state": "South Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03636256" }, { "nct_id": "NCT05774002", "title": "Psychological Assessment of Scoliosis Patients Undergoing Surgical Management", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adolescent Idiopathic Scoliosis (AIS)", "Mental Health" ], "interventions": [ { "name": "Aims to Decrease Anxiety and Pain Treatment (ADAPT)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "10 Years to 19 Years" }, "enrollment_count": 120, "start_date": "2023-10-06", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05774002" }, { "nct_id": "NCT04770402", "title": "Acupuncture for Chemo-Induced Peripheral Neuropathy in Multiple Myeloma Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chemotherapy-induced Peripheral Neuropathy" ], "interventions": [ { "name": "Acupuncture", "type": "OTHER" }, { "name": "Standard of Care CIPN management", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2021-09-15", "completion_date": "2023-04-06", "has_results": true, "last_update_posted_date": "2025-01-27", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04770402" }, { "nct_id": "NCT03876301", "title": "Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Blood Coagulation Disorder", "Blood Coagulation Disorders, Inherited", "Coagulation Protein Disorders", "Hemophilia A", "Genetic Diseases, Inborn", "Genetic Diseases, X-Linked", "Hematologic Diseases", "Hemorrhagic Disorders", "Factor VIII Deficiency" ], "interventions": [ { "name": "Standard of Care FVIII Replacement therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Spark Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 25, "start_date": "2019-01-21", "completion_date": "2023-05-02", "has_results": false, "last_update_posted_date": "2023-07-10", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 6, "location_summary": "San Francisco, California • Gainesville, Florida • Atlanta, Georgia + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Madison", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT03876301" }, { "nct_id": "NCT06285812", "title": "Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Otitis Media Acute" ], "interventions": [ { "name": "OtoSight Middle Ear Scope", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "PhotoniCare, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 700, "start_date": "2024-01-10", "completion_date": "2026-07", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 7, "location_summary": "Washington D.C., District of Columbia • Miami, Florida • Orlando, Florida + 4 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Rochester", "state": "New York" }, { "city": "Gresham", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT06285812" }, { "nct_id": "NCT03824119", "title": "Postpartum NSAIDS and Maternal Hypertension", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Preeclampsia", "Gestational Hypertension", "Superimposed Preeclampsia", "Chronic Hypertension in Obstetric Context" ], "interventions": [ { "name": "Ibuprofen 600 mg", "type": "DRUG" }, { "name": "Standard Postpartum Care without NSAIDs", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 200, "start_date": "2018-12-11", "completion_date": "2022-12-11", "has_results": false, "last_update_posted_date": "2020-11-06", "last_synced_at": "2026-10-21T05:20:10.840Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03824119" } ] }